Alligator Bioscience

Alligator Bioscience AB (Lund, Sweden) is an early-stage drug discovery and development company focusing on immunotherapy of cancer. 

Compared to conventional systemic immunotherapy, Alligator has pioneered a new treatment concept aiming at local administration.

The treatment concept is expected to result in better efficacy and fewer adverse events compared to systemically administered immunotherapies.

http://alligatorbioscience.se/

For more information, please contact:

Peter Benson, MSc

Chairman & General Partner

Phone: +45 4080 4869